v3 Template
C

Cure Ventures

Life Sciences / Biotechnology ~620 employees
Founded
--
Employees (Est.)
~620
31 leaders known
Total Funding
$350.0M
Funding Rounds
1
Last Funding
2023-04-04

About Cure Ventures

Cure Ventures is a life sciences venture capital firm focused on company formation around groundbreaking therapeutic discoveries. They work alongside entrepreneurs to drive life-changing cures for patients, emphasizing a culture of respect and scientific fact, with a mission to embrace evidence, increase success, and save lives.

Products & Services

XenImmune:Leverages the robust immune response to target tumors in innovative ways.
Tasca Therapeutics:Unlocks post-translational modification to expand the druggable proteome.

Specialties

Company Formation Therapeutic Drug Discovery Venture Capital in Life Sciences

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Inaugural Fund
T: -
FT: Inaugural Fund 		A: 350000000
MR: -
FA: 350 million
FAN: 350000000 		D: 2023-04-04
FD: 2023-04-04 		6 investors
Inaugural Fund Latest
2023-04-04
$350.0M
6 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

Dr. Milenko Cicmil

Founder, Tasca Therapeutics

D

Dave Fallace

Founding Partner

D

Dr. Xu Wu

Co-Founder

M

Milenko Cicmil

Venture Partner

W

William Amsbaugh

CTO and Partner

D

David Fallace

Managing Partner

View 28 more team members with Pro

Unlock Full Team Directory

Recent News

Cure Ventures Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
curevc.com
Industries
Life Sciences / Biotechnology
Company Size
~620 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro